Centre Hospitalier Départmental La Roche sur Yon

La Roche-sur-Yon 85925

0 studies enrolling now · 2 studies all time

What they study most

Indolent Non-Hodgkin's Lymphomas, Multiple Myeloma

Studies at this site

• A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy — Completed
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early